glp 1 disorders Glucagon-like peptide-1 medicines in neurological and psychiatric Can one drug do it
Description
[2025 Mar 13]
doi:10.1016/j.cmet.2013.04.008
None contain GLP-1 drugs
has received travel support from Novartis and Sanofi and research funding from Novartis
RR, relative risk
Even if one chooses not to take a GLP-1 to manage weight loss, adherence to a Mediterranean-style diet, adequate hydration, and resistance training combined with aerobic exercise is recommended for weight loss and preservation of muscle mass.
